CBC, RBC Indices, Reticulocytes, and Anemia Patterns

CBC Pattern Reading for MLT Hematology

The official ASCP MLT content guideline places Hematology at 20-25% of the total examination and includes hematology physiology, disease states, laboratory testing, and hemostasis. For the CBC portion, the MLT task is usually practical: recognize whether the numbers fit, calculate common indices, correlate them with a smear, and decide when a result needs review before release.

A complete blood count (CBC) is not one result. It is a set of related measurements. Hemoglobin and hematocrit describe oxygen-carrying mass. RBC count describes cell number. The indices describe average RBC size and hemoglobinization. RDW describes variation in size. The platelet and WBC parts of the CBC are interpreted separately, but RBC abnormalities can affect the whole report when nucleated RBCs, clots, agglutination, or fragments are present.

Core RBC formulas

Use the ASCP exam-purpose reference ranges as a starting frame: RBC 4.00-6.00 x 10^6/uL, Hgb 12.0-18.0 g/dL, Hct 35-50%, MCV 76-100 fL, MCH 26-34 pg, MCHC 32-36 g/dL, RDW 11.5-14.5%, and reticulocytes 0.5-2.5% or 20-115 x 10^3/uL. Local clinical laboratories may use narrower sex- or age-specific ranges, but ASCP's composite ranges are the exam reference point.

First pass: does the CBC make physiologic sense?

A quick rule is the rule of three: RBC x 3 approximates Hgb, and Hgb x 3 approximates Hct in many normocytic, normochromic samples. It is only a screen, not a reporting rule. A major mismatch can suggest cold agglutinins, lipemia or icterus interfering with hemoglobin, RBC fragments, severe microcytosis, recent transfusion, or specimen problems.

A very high MCHC is especially useful because true MCHC above the usual range is uncommon. Spherocytes may mildly increase MCHC, but values such as 38-40 g/dL often point to analytic interference. Cold agglutinins can falsely lower RBC count while raising MCV and MCHC. The MLT response is to check flags, inspect the smear for agglutination, warm and rerun if required by procedure, and document the corrective action.

Classifying anemia by MCV and reticulocytes

Start with whether Hgb/Hct are low. Then use MCV to classify the anemia and reticulocytes to decide whether the marrow is responding.

Iron deficiency usually shows microcytosis, hypochromia, increased RDW, low ferritin, and high total iron-binding capacity. Thalassemia trait can also be microcytic but often has many target cells, a relatively preserved or increased RBC count, and RDW that may be less striking. Anemia of chronic inflammation often has low serum iron with normal or increased ferritin and lower TIBC than iron deficiency.

Macrocytic anemia should not be called megaloblastic from MCV alone. Megaloblastic morphology includes macro-ovalocytes and hypersegmented neutrophils because nuclear maturation lags behind cytoplasmic maturation. Non-megaloblastic macrocytosis may come from liver disease, alcohol exposure, hypothyroidism, or reticulocytosis. Reticulocytes are larger than mature RBCs, so a hemolytic response can lift the MCV.

Smear clues that change the interpretation

Use morphology as evidence, not decoration. Schistocytes point toward fragmentation and can fit microangiopathic hemolysis, disseminated intravascular coagulation, mechanical valve injury, or severe burns depending on context. Spherocytes fit hereditary spherocytosis or warm autoimmune hemolysis. Target cells fit thalassemia, liver disease, hemoglobin C disease, and postsplenectomy patterns.

Teardrop cells suggest marrow distortion or infiltration when prominent. Howell-Jolly bodies suggest absent or decreased splenic function. Basophilic stippling can be seen with thalassemia, lead exposure, or disordered heme synthesis.

For MLT exam questions, expect one best answer from the data given. Do not overdiagnose from one number. A microcytic anemia with low ferritin and high TIBC is iron deficiency pattern. A normocytic anemia with high reticulocytes and high LDH is hemolysis or blood loss pattern. A macrocytic anemia with macro-ovalocytes and hypersegmented neutrophils is megaloblastic pattern.

Practical release mindset

Before reporting, ask: Do the indices agree with Hgb and Hct? Is MCHC plausible? Did the analyzer flag RBC agglutination, fragments, nucleated RBCs, or dimorphic RBCs? Does the smear support the automated result? If the answer is no, follow the local SOP for smear review, repeat analysis, correction, comment, or supervisor/pathologist escalation.